The solid progress of nanomedicine

Drug Deliv Transl Res. 2020 Jun;10(3):726-729. doi: 10.1007/s13346-020-00743-2.

Abstract

This commentary article conveys the views of the board of the Nanomedicine and Nanoscale Delivery Focus Group of the Controlled Release Society regarding the decision of the United States National Cancer Institute (NCI) in halting funding for the Centers of Cancer Nanotechnology Excellence (CCNEs), and the subsequent editorial articles that broadened this discussion. Graphical abstract.

Keywords: Cancer therapy; Clinical translation; Nanomedicine; Nanotechnology; Reproducibility.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Focus Groups
  • Humans
  • Nanomedicine / economics*
  • National Cancer Institute (U.S.) / organization & administration*
  • Neoplasms / drug therapy*
  • United States